ORIFARM PI A/S: Financial statements 2022
CVR: 27347177
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -73,000 and a net result of DKK 182,945,000 compared with DKK 206,026,000 the year before. Equity in the 2022 report amounted to DKK 687,448,000. The solvency ratio was 84.1%.
- Gross Profit
- DKK -73,000
- Profit/Loss
- DKK 182,945,000
- Equity
- DKK 687,448,000
- Total Assets
- DKK 817,787,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -73K | 182.9M | 687.4M | 0 |
| 2021 | - | -76K | 206M | 760M | 0 |
| 2020 | - | -57K | 208.7M | 563.8M | 0 |
| 2019 | - | -71K | 191.8M | 554.4M | - |
| 2018 | - | -169K | 149M | 502.6M | - |
Official annual report
Keep an eye on ORIFARM PI A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ORIFARM PI A/S has published its annual report for 2021. Gross profit came to DKK -76,000, and the net result was DKK 206,026,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.